• Omkar Soni
• Om Sankpal
• Jagannath Yele
• Akash Jadhav
• Dr. Vivekkumar Redasani

Amlodipine, a calcium channel blocker, is widely prescribed in India for the treatment of hypertension and angina. This review provides an in-depth market analysis of amlodipine in the Indian pharmaceutical landscape. The paper explores current usage trends, market share, pricing dynamics, regulatory environment, and competition. Additionally, it highlights the future outlook based on epidemiological and economic factors.

Amlodipine, Calcium Channel Blocker, Hypertension, Angina, Indian Pharmaceutical Market, Market Analysis, Generic Drugs, Pricing Dynamics, Regulatory Environment, Antihypertensive Agents, Cardiovascular Drugs, NPPA, Branded vs. Generic, Competitive Landscape, Epidemiology, Healthcare Economics.

"Market Analysis of Amlodipine as an Antihypertensive Agent in India", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.12, Issue 5, page no.l612-l620, May-2025, Available :http://www.jetir.org/papers/JETIR2505C60.pdf

"Market Analysis of Amlodipine as an Antihypertensive Agent in India", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.12, Issue 5, page no. ppl612-l620, May-2025, Available at : http://www.jetir.org/papers/JETIR2505C60.pdf